Comparable stake leader
HIGHBRIDGE CAPITAL MANAGEMENT LLC
SEC ownership of Inmune Bio, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001711754.
Disclosed value leader
Xencor Inc
Comparable rows
3/50
Latest evidence
02 Jul 2026
- Public ticker
- INMB on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
HIGHBRIDGE CAPITAL MANAGEMENT LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
3 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
HIGHBRIDGE CAPITAL MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
02 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001711754
- Issuer location
- Boca Raton, FL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Inmune Bio, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HIGHBRIDGE CAPITAL MANAGE...
Disclosed value leader
Xencor Inc
Comparable rows
3/50
Latest evidence
02 Jul 2026
13D/G
3/4/5
13F
Lead comparable stake: 5.2%
47 rows are not safely comparable across share classes.
13D/G row: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
HIGHBRIDGE CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 5.2%.
3 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HIGHBRIDGE CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 3
HIGHBRIDGE CAPITAL MANAGEMENT LLC
5.2%
CVI Investments, Inc.
4.9%
Praetorian PR LLC
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
5.2%
Reported 13D/G
· 30 Jun 2025
|
$3,359,664
1,454,400 shares
|
$0 | 30 Jun 2025 |
| CVI Investments, Inc. |
13D/G
|
4.9%
Reported 13D/G
· 30 Jun 2025
|
$3,225,404
1,396,279 shares
|
-$239,596 | 30 Jun 2025 |
| Praetorian PR LLC |
13D/G
Kupperman Harris
|
3.4%
Reported 13D/G
· 30 Jun 2025
|
$2,127,972
921,200 shares
|
-$1,700,160 | 30 Jun 2025 |
| Xencor Inc |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$13,104,454
1,885,533 shares
|
— | 03 Sep 2021 |
| Raymond Joseph Tesi |
3/4/5
President and CEO, Director, 10%+ Owner
|
—
mixed-class rows
|
$9,907,426
1,833,368 shares
mixed-class rows
|
— | 05 Dec 2024 |
| Mark William Lowdell |
3/4/5
Chief Scientific Officer
|
—
mixed-class rows
|
$1,715,359
2,225,229 shares
mixed-class rows
|
— | 02 Jul 2026 |
| David J. Moss |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$1,463,217
2,213,897 shares
mixed-class rows
|
— | 02 Jul 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$1,151,471
706,424 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 07 Nov 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to Inmune Bio, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
Xencor Inc
Net 12M change
$0
Latest report
15 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Xencor Inc | 10%+ Owner | $13,104,454 | Mixed | 03 Sep 2021 | ||
| Raymond Joseph Tesi | President and CEO, Director, 10%+ Owner | $9,907,426 | Filing P/S | 05 Dec 2024 | ||
| Mark William Lowdell | Chief Scientific Officer | $1,715,359 | Mixed | 02 Jul 2026 | ||
| David J. Moss | Chief Executive Officer, Director | $1,463,217 | Mixed | 02 Jul 2026 | ||
| Scott Juda | Director | $97,636 | Mixed | 02 Jul 2026 | ||
| Timothy J. Schroeder | Director | Mixed | 01 Dec 2025 | |||
| James Sapirstein | Director | Mixed | 15 Sep 2026 | |||
| R. Duane Clark | Director | Mixed | 15 Sep 2026 | |||
| James Kelly Ganjei | Director | Mixed | 01 Dec 2025 | |||
| Cory Randall Ellspermann | Cfo | Mixed | 01 Dec 2025 | |||
| Edgardo Baracchini Jr. | Director | Mixed | 14 May 2024 | |||
| Marcia Allen | Director | Mixed | 01 Dec 2025 |
Recent insider transactions for Inmune Bio, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| R. Duane Clark | INMB | Stock Options | Award | 100,000 | 100,000 | 15 Sep 2026 | Direct | |||
| James Sapirstein | INMB | Stock Options | Award | 100,000 | 100,000 | 15 Sep 2026 | Direct | |||
| Scott Juda | INMB | Common Stock | Options Exercise | 20.7% | 14,801 | 86,404 | 02 Jul 2026 | Direct | ||
| Scott Juda | INMB | Common Stock Purchase Warrant | Exercise of in-the-money or at-the-money derivative security | -50% | -14,801 | 14,802 | 02 Jul 2026 | Direct | ||
| Mark William Lowdell | INMB | Common Stock | Options Exercise | 0.48% | 7,211 | 1,518,017 | 02 Jul 2026 | Direct | ||
| Mark William Lowdell | INMB | Common Stock Purchase Warrant | Exercise of in-the-money or at-the-money derivative security | -50% | -7,211 | 7,212 | 02 Jul 2026 | Direct | ||
| David J. Moss | INMB | Common Stock | Options Exercise | 0.7% | 9,014 | 1,294,883 | 02 Jul 2026 | Direct | ||
| David J. Moss | INMB | Common Stock Purchase Warrant | Exercise of in-the-money or at-the-money derivative security | -50% | -9,014 | 9,014 | 02 Jul 2026 | Direct | ||
| David J. Moss | INMB | Option (right to buy) | Award | 750,000 | 750,000 | 01 Dec 2025 | Direct | |||
| Mark William Lowdell | INMB | Option (right to buy) | Award | 600,000 | 600,000 | 01 Dec 2025 | Direct | |||
| Cory Randall Ellspermann | INMB | Option (right to buy) | Award | 300,000 | 300,000 | 01 Dec 2025 | Direct | |||
| Timothy J. Schroeder | INMB | Option (right to buy) | Award | 150,000 | 150,000 | 01 Dec 2025 | Direct | |||
| Scott Juda | INMB | Option (right to buy) | Award | 150,000 | 150,000 | 01 Dec 2025 | Direct | |||
| James Kelly Ganjei | INMB | Option (right to buy) | Award | 150,000 | 150,000 | 01 Dec 2025 | Direct | |||
| Marcia Allen | INMB | Option (right to buy) | Award | 150,000 | 150,000 | 01 Dec 2025 | Direct | |||
| Timothy J. Schroeder | INMB | Stock Option (right to buy) | Award | 366,000 | 108,000 | 18 Nov 2025 | Direct | |||
| Timothy J. Schroeder | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -366,000 | 0 | 18 Nov 2025 | Direct | ||
| David J. Moss | INMB | Stock Option (right to buy) | Award | 1,478,000 | 400,000 | 18 Nov 2025 | Direct | |||
| David J. Moss | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -1,478,000 | 0 | 18 Nov 2025 | Direct | ||
| Mark William Lowdell | INMB | Stock Option (right to buy) | Award | 924,000 | 400,000 | 18 Nov 2025 | Direct | |||
| Mark William Lowdell | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -924,000 | 0 | 18 Nov 2025 | Direct | ||
| Scott Juda | INMB | Stock Option (right to buy) | Award | 366,000 | 108,000 | 18 Nov 2025 | Direct | |||
| Scott Juda | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -366,000 | 0 | 18 Nov 2025 | Direct | ||
| James Kelly Ganjei | INMB | Stock Option (right to buy) | Award | 366,000 | 108,000 | 18 Nov 2025 | Direct | |||
| James Kelly Ganjei | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -366,000 | 0 | 18 Nov 2025 | Direct | ||
| Cory Randall Ellspermann | INMB | Stock Option (right to buy) | Award | 245,000 | 75,000 | 18 Nov 2025 | Direct | |||
| Cory Randall Ellspermann | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -245,000 | 0 | 18 Nov 2025 | Direct | ||
| Marcia Allen | INMB | Stock Option (right to buy) | Award | 258,000 | 108,000 | 18 Nov 2025 | Direct | |||
| Marcia Allen | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -258,000 | 0 | 18 Nov 2025 | Direct |
* marks a reported price that did not pass the local price check.